Pill vs. injection: new hope for acromegaly control
NCT ID NCT04837040
Summary
This study is testing if a daily pill called paltusotine can safely maintain control of acromegaly in people who are already stable on standard injectable treatments. About 58 adults will be randomly assigned to either keep taking the pill or switch to a placebo (inactive pill) for 36 weeks to see if the pill works. The main goal is to see if the pill keeps a key hormone (IGF-1) at a normal level and if it helps with symptoms like joint pain and fatigue.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Crinetics Study Site
Los Angeles, California, 90048, United States
-
Crinetics Study Site
Torrance, California, 90502, United States
-
Crinetics Study Site
Baltimore, Maryland, 21205, United States
-
Crinetics Study Site
Boston, Massachusetts, 02114, United States
-
Crinetics Study Site
Philadelphia, Pennsylvania, 19104, United States
-
Crinetics Study Site
Pittsburgh, Pennsylvania, 15212, United States
-
Crinetics Study Site
Nashville, Tennessee, 37203, United States
-
Crinetics Study Site
CABA, Buenos Aires, C1012AAR, Argentina
-
Crinetics Study Site
Ciudad Autonoma de Buenos Aire, Buenos Aires, C1405BCH, Argentina
-
Crinetics Study Site
Córdoba, X5000, Argentina
-
Crinetics Study Site
Ghent, 9000, Belgium
-
Crinetics Study Site
Fortaleza, Ceará, 60430-275, Brazil
-
Crinetics Study Site
Curitiba, Paraná, 80030-110, Brazil
-
Crinetics Study Site
Porto Alegre, Rio Grande do Sul, 90410-000, Brazil
-
Crinetics Study Site
Rio de Janeiro, 20231-092, Brazil
-
Crinetics Study Site
Rio de Janeiro, 21941-913, Brazil
-
Crinetics Study Site
Sofia, 1431, Bulgaria
-
Crinetics Study Site
Bron, 69677, France
-
Crinetics Study Site
Pessac, 33604, France
-
Crinetics Study Site
Budapest, 1083, Hungary
-
Crinetics Study Site
Pécs, 7624, Hungary
-
Crinetics Study Site
Beersheba, 8410101, Israel
-
Crinetics Study Site
Petah Tikva, 4941480, Israel
-
Crinetics Study Site
Roma, 00168, Italy
-
Crinetics Study Site
San Isidro, Lima region, 15023, Peru
-
Crinetics Study Site
Bydgoszcz, 85-605, Poland
-
Crinetics Study Site
Poznan, 60-355, Poland
-
Crinetics Study Site
Kemerovo, Kemerovo Oblast, 650066, Russia
-
Crinetics Study Site
Novosibirsk, Novosibirsk Oblast, 630005, Russia
-
Crinetics Study Site
Novosibirsk, Novosibirsk Oblast, 630087, Russia
-
Crinetics Study Site
Samara, Samara Oblast, 443041, Russia
-
Crinetics Study Site
Kazan', Tatarstan Republic, 420097, Russia
-
Crinetics Study Site
Moscow, 117186, Russia
-
Crinetics Study Site
Moscow, 119435, Russia
-
Crinetics Study Site
Moscow, 125008, Russia
-
Crinetics Study Site
Belgrade, 11000, Serbia
-
Crinetics Study Site
Sheffield, South Yorkshire, S102JF, United Kingdom
-
Crinetics Study Site
Coventry, West Midlands, CV2 2DX, United Kingdom
-
Crinetics Study Site
London, W12 0HS, United Kingdom
Conditions
Explore the condition pages connected to this study.